Go Pro

Amrize (AMRZ) Financials

Amrize logo
$44.68 +0.39 (+0.88%)
As of 08/28/2026 03:58 PM Eastern
Annual Income Statements for Amrize

Annual Income Statements for Amrize

This table shows Amrize's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
956 1,274 1,185
Consolidated Net Income / (Loss)
955 1,273 1,182
Net Income / (Loss) Continuing Operations
955 1,273 1,182
Total Pre-Tax Income
1,303 1,628 1,497
Total Operating Income
1,888 2,195 1,906
Total Gross Profit
2,769 3,070 3,034
Total Revenue
11,677 11,704 11,815
Operating Revenue
11,677 11,704 11,815
Total Cost of Revenue
8,908 8,634 8,781
Operating Cost of Revenue
8,908 8,634 8,781
Total Operating Expenses
881 875 1,128
Selling, General & Admin Expense
898 944 1,128
Impairment Charge
15 2.00 15
Other Special Charges / (Income)
-32 -71 -15
Total Other Income / (Expense), net
-585 -567 -409
Interest & Investment Income
-549 -512 -413
Other Income / (Expense), net
-36 -55 4.00
Income Tax Expense
361 368 326
Other Gains / (Losses), net
13 13 11
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.00 -1.00 -3.00
Basic Earnings per Share
$1.73 $2.30 $2.14
Weighted Average Basic Shares Outstanding
553.10M 553.10M 553.10M
Diluted Earnings per Share
$1.73 $2.30 $2.14
Weighted Average Diluted Shares Outstanding
553.10M 553.10M 553.60M
Weighted Average Basic & Diluted Shares Outstanding
- - 553.08M

Quarterly Income Statements for Amrize

This table shows Amrize's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
474 553 -87 417 545 -116 478
Consolidated Net Income / (Loss)
473 552 -87 416 543 -118 476
Net Income / (Loss) Continuing Operations
473 552 -87 416 543 -118 476
Total Pre-Tax Income
620 703 -133 537 689 -145 621
Total Operating Income
754 844 -16 657 778 -76 711
Total Gross Profit
979 1,042 222 941 1,086 211 993
Total Revenue
3,243 3,446 2,081 3,218 3,675 2,178 3,494
Operating Revenue
3,243 3,446 2,081 3,218 3,675 2,178 3,494
Total Cost of Revenue
2,264 2,404 1,859 2,277 2,589 1,967 2,501
Operating Cost of Revenue
2,264 2,404 1,859 2,277 2,589 1,967 2,501
Total Operating Expenses
225 198 238 284 308 287 282
Selling, General & Admin Expense
228 241 239 286 312 292 283
Impairment Charge
2.00 0.00 - 2.00 0.00 - 2.00
Other Special Charges / (Income)
-5.00 -43 -1.00 -4.00 -4.00 -5.00 -3.00
Total Other Income / (Expense), net
-134 -141 -117 -120 -89 -69 -90
Interest & Investment Income
-134 -130 -118 -121 -89 -70 -89
Other Income / (Expense), net
0.00 -11 1.00 1.00 0.00 1.00 -1.00
Income Tax Expense
149 155 -46 122 150 -27 146
Other Gains / (Losses), net
2.00 4.00 - 1.00 4.00 - 1.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.00 -1.00 0.00 -1.00 -2.00 -2.00 -2.00
Basic Earnings per Share
$0.86 $1.00 ($0.16) $0.75 $0.99 ($0.21) $0.87
Weighted Average Basic Shares Outstanding
553.10M 553.10M 553.10M 553.10M 553.10M 553.20M 552.50M
Diluted Earnings per Share
$0.86 $1.00 ($0.16) $0.75 $0.98 ($0.21) $0.86
Weighted Average Diluted Shares Outstanding
553.10M 553.10M 553.10M 553.10M 553.90M 553.20M 553.60M
Weighted Average Basic & Diluted Shares Outstanding
- - - 553.08M 553.08M 553.54M 546.93M

Annual Cash Flow Statements for Amrize

This table details how cash moves in and out of Amrize's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
756 478 337
Net Cash From Operating Activities
2,036 2,282 2,208
Net Cash From Continuing Operating Activities
2,036 2,282 2,208
Net Income / (Loss) Continuing Operations
955 1,273 1,182
Consolidated Net Income / (Loss)
955 1,273 1,182
Depreciation Expense
851 889 914
Non-Cash Adjustments To Reconcile Net Income
102 117 160
Changes in Operating Assets and Liabilities, net
128 3.00 -48
Net Cash From Investing Activities
-2,025 -1,208 -361
Net Cash From Continuing Investing Activities
-2,025 -1,208 -361
Purchase of Property, Plant & Equipment
-630 -642 -788
Acquisitions
-1,607 -249 -86
Sale of Property, Plant & Equipment
49 61 21
Other Investing Activities, net
163 -378 492
Net Cash From Financing Activities
734 -537 -1,555
Net Cash From Continuing Financing Activities
734 -537 -1,555
Repayment of Debt
-656 -381 -5,697
Issuance of Debt
1,465 230 3,417
Other Financing Activities, net
-75 -386 725
Effect of Exchange Rate Changes
11 -59 45

Quarterly Cash Flow Statements for Amrize

This table details how cash moves in and out of Amrize's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
60 1,165 -1,011 27 225 1,096 -823 -370
Net Cash From Operating Activities
623 1,727 -856 415 854 1,804 -896 421
Net Cash From Continuing Operating Activities
623 1,727 -856 415 854 1,804 -896 421
Net Income / (Loss) Continuing Operations
552 292 -87 409 543 298 -118 487
Consolidated Net Income / (Loss)
552 292 -87 409 543 298 -118 487
Depreciation Expense
228 225 218 226 231 244 236 258
Non-Cash Adjustments To Reconcile Net Income
36 55 30 27 20 78 33 59
Changes in Operating Assets and Liabilities, net
-193 1,155 -1,017 -247 60 1,184 -1,047 -383
Net Cash From Investing Activities
-425 -352 -60 49 -202 -150 -659 -237
Net Cash From Continuing Investing Activities
-425 -352 -60 49 -202 -150 -659 -237
Purchase of Property, Plant & Equipment
-221 -84 -211 -237 -185 -157 -272 -248
Other Investing Activities, net
-202 -68 158 357 -14 -2.00 33 16
Net Cash From Financing Activities
-143 -163 -97 -469 -419 -577 743 -555
Net Cash From Continuing Financing Activities
-143 -163 -97 -469 -419 -577 743 -555
Repayment of Debt
-49 -343 -8.00 -5,684 -6.00 1.00 0.00 -1.00
Issuance of Debt
20 210 22 4,328 -386 -547 777 -42
Other Financing Activities, net
-114 -30 -111 887 -27 -31 -34 -30
Effect of Exchange Rate Changes
5.00 -47 2.00 32 -8.00 19 -11 1.00

Annual Balance Sheets for Amrize

This table presents Amrize's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
23,805 24,209
Total Current Assets
4,781 4,613
Cash & Equivalents
1,585 1,922
Accounts Receivable
1,069 1,113
Inventories, net
1,452 1,490
Prepaid Expenses
143 88
Plant, Property, & Equipment, net
0.00 7,936
Total Noncurrent Assets
19,024 11,660
Goodwill
8,917 9,044
Intangible Assets
1,832 1,728
Other Noncurrent Operating Assets
8,275 888
Total Liabilities & Shareholders' Equity
23,805 24,209
Total Liabilities
13,891 11,088
Total Current Liabilities
2,550 2,885
Short-Term Debt
134 333
Accounts Payable
1,374 1,530
Other Current Liabilities
1,042 1,022
Total Noncurrent Liabilities
11,341 8,203
Long-Term Debt
8,498 4,936
Noncurrent Deferred & Payable Income Tax Liabilities
936 1,042
Other Noncurrent Operating Liabilities
1,907 2,225
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
9,914 13,121
Total Preferred & Common Equity
9,915 13,125
Total Common Equity
9,915 13,125
Common Stock
0.00 12,575
Retained Earnings
0.00 930
Treasury Stock
0.00 0.00
Accumulated Other Comprehensive Income / (Loss)
-606 -380
Noncontrolling Interest
-1.00 -4.00

Quarterly Balance Sheets for Amrize

This table presents Amrize's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
23,782 24,035 24,269 24,603
Total Current Assets
4,326 4,569 4,284 4,584
Cash & Equivalents
601 826 1,099 729
Accounts Receivable
1,892 2,046 1,358 2,057
Inventories, net
1,641 1,511 1,567 1,553
Prepaid Expenses
192 186 260 245
Plant, Property, & Equipment, net
0.00 7,837 8,366 8,454
Total Noncurrent Assets
19,456 11,629 11,619 11,565
Goodwill
9,029 8,993 9,070 9,044
Intangible Assets
1,797 1,762 1,703 1,682
Other Noncurrent Operating Assets
8,630 874 846 839
Total Liabilities & Shareholders' Equity
23,782 24,035 24,269 24,603
Total Liabilities
11,349 11,137 11,181 11,745
Total Current Liabilities
3,143 3,152 3,054 4,154
Short-Term Debt
937 879 1,110 1,769
Accounts Payable
1,355 1,322 1,021 1,347
Other Current Liabilities
851 951 923 1,038
Total Noncurrent Liabilities
8,206 7,985 8,127 7,591
Long-Term Debt
5,261 4,932 4,936 4,235
Noncurrent Deferred & Payable Income Tax Liabilities
928 946 1,104 1,146
Other Noncurrent Operating Liabilities
2,017 2,107 2,087 2,210
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
12,433 12,898 13,088 12,858
Total Preferred & Common Equity
12,434 12,901 13,094 12,866
Total Common Equity
12,434 12,901 13,094 12,866
Common Stock
12,736 12,740 12,753 12,596
Retained Earnings
59 601 785 997
Treasury Stock
0.00 0.00 0.00 -194
Accumulated Other Comprehensive Income / (Loss)
-361 -440 -444 -533
Noncontrolling Interest
-1.00 -3.00 -6.00 -8.00

Annual Metrics And Ratios for Amrize

This table displays calculated financial ratios and metrics derived from Amrize's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - -
Revenue Growth
0.00% 0.23% 0.95%
EBITDA Growth
0.00% 12.06% -6.77%
EBIT Growth
0.00% 15.55% -10.75%
NOPAT Growth
0.00% 24.46% -12.24%
Net Income Growth
0.00% 33.30% -7.15%
EPS Growth
0.00% 32.95% -6.96%
Operating Cash Flow Growth
0.00% 12.08% -3.24%
Free Cash Flow Firm Growth
0.00% 0.00% 112.13%
Invested Capital Growth
0.00% 0.00% -2.12%
Revenue Q/Q Growth
0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00%
Profitability Metrics
- - -
Gross Margin
23.71% 26.23% 25.68%
EBITDA Margin
23.15% 25.88% 23.90%
Operating Margin
16.17% 18.75% 16.13%
EBIT Margin
15.86% 18.28% 16.17%
Profit (Net Income) Margin
8.18% 10.88% 10.00%
Tax Burden Percent
73.29% 78.19% 78.96%
Interest Burden Percent
70.36% 76.07% 78.38%
Effective Tax Rate
27.71% 22.60% 21.78%
Return on Invested Capital (ROIC)
0.00% 20.03% 8.88%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 7.95% 2.94%
Return on Net Nonoperating Assets (RNNOA)
0.00% 5.65% 1.32%
Return on Equity (ROE)
0.00% 25.68% 10.20%
Cash Return on Invested Capital (CROIC)
0.00% -179.97% 11.03%
Operating Return on Assets (OROA)
0.00% 8.99% 7.95%
Return on Assets (ROA)
0.00% 5.35% 4.92%
Return on Common Equity (ROCE)
0.00% 25.68% 10.21%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,365 1,699 1,491
NOPAT Margin
11.69% 14.52% 12.62%
Net Nonoperating Expense Percent (NNEP)
0.00% 12.09% 5.94%
Return On Investment Capital (ROIC_SIMPLE)
- 9.16% 8.05%
Cost of Revenue to Revenue
76.29% 73.77% 74.32%
SG&A Expenses to Revenue
7.69% 8.07% 9.55%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
7.54% 7.48% 9.55%
Earnings before Interest and Taxes (EBIT)
1,852 2,140 1,910
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,703 3,029 2,824
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 0.00 2.26
Price to Tangible Book Value (P/TBV)
0.00 0.00 11.93
Price to Revenue (P/Rev)
0.00 0.00 2.53
Price to Earnings (P/E)
0.00 0.00 25.26
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 3.96%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 2.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 2.82
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 11.79
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 17.43
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 22.32
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 15.07
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 17.98
Leverage & Solvency
- - -
Debt to Equity
0.00 0.87 0.40
Long-Term Debt to Equity
0.00 0.86 0.37
Financial Leverage
0.00 0.71 0.45
Leverage Ratio
0.00 2.40 2.07
Compound Leverage Factor
0.00 1.83 1.63
Debt to Total Capital
0.00% 46.54% 28.45%
Short-Term Debt to Total Capital
0.00% 0.72% 1.80%
Long-Term Debt to Total Capital
0.00% 45.82% 26.65%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% -0.01% -0.02%
Common Equity to Total Capital
0.00% 53.46% 71.58%
Debt to EBITDA
0.00 2.85 1.87
Net Debt to EBITDA
0.00 2.33 1.19
Long-Term Debt to EBITDA
0.00 2.81 1.75
Debt to NOPAT
0.00 5.08 3.53
Net Debt to NOPAT
0.00 4.15 2.24
Long-Term Debt to NOPAT
0.00 5.00 3.31
Altman Z-Score
0.00 0.00 2.52
Noncontrolling Interest Sharing Ratio
0.00% -0.01% -0.02%
Liquidity Ratios
- - -
Current Ratio
0.00 1.87 1.64
Quick Ratio
0.00 1.25 1.06
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -15,262 1,851
Operating Cash Flow to CapEx
350.43% 392.77% 287.87%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00
Efficiency Ratios
- - -
Asset Turnover
0.00 0.49 0.49
Accounts Receivable Turnover
0.00 10.95 10.79
Inventory Turnover
0.00 5.95 5.85
Fixed Asset Turnover
0.00 0.00 0.00
Accounts Payable Turnover
0.00 6.28 6.03
Days Sales Outstanding (DSO)
0.00 33.34 33.81
Days Inventory Outstanding (DIO)
0.00 61.38 62.41
Days Payable Outstanding (DPO)
0.00 58.09 60.52
Cash Conversion Cycle (CCC)
0.00 36.64 35.70
Capital & Investment Metrics
- - -
Invested Capital
0.00 16,961 16,601
Invested Capital Turnover
0.00 1.38 0.70
Increase / (Decrease) in Invested Capital
0.00 16,961 -360
Enterprise Value (EV)
0.00 0.00 33,282
Market Capitalization
0.00 0.00 29,939
Book Value per Share
$0.00 $17.93 $23.97
Tangible Book Value per Share
$0.00 ($1.51) $4.54
Total Capital
0.00 18,546 18,523
Total Debt
0.00 8,632 5,269
Total Long-Term Debt
0.00 8,498 4,936
Net Debt
0.00 7,047 3,347
Capital Expenditures (CapEx)
581 581 767
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 780 235
Debt-free Net Working Capital (DFNWC)
0.00 2,365 2,157
Net Working Capital (NWC)
0.00 2,231 1,824
Net Nonoperating Expense (NNE)
410 426 309
Net Nonoperating Obligations (NNO)
0.00 7,047 3,347
Total Depreciation and Amortization (D&A)
851 889 914
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 6.66% 1.99%
Debt-free Net Working Capital to Revenue
0.00% 20.21% 18.26%
Net Working Capital to Revenue
0.00% 19.06% 15.44%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.14
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 553.10M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.14
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 553.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 553.08M
Normalized Net Operating Profit after Tax (NOPAT)
1,353 1,645 1,491
Normalized NOPAT Margin
11.58% 14.06% 12.62%
Pre Tax Income Margin
11.16% 13.91% 12.67%
Debt Service Ratios
- - -
EBIT to Interest Expense
0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Amrize

This table displays calculated financial ratios and metrics derived from Amrize's official financial filings.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - 0.00 - - 553,082,525.00 553,536,609.00
DEI Adjusted Shares Outstanding
- - 0.00 - - 553,082,525.00 553,536,609.00
DEI Earnings Per Adjusted Shares Outstanding
- - 0.00 - - -0.21 0.86
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 0.00% 0.00% -0.71% 6.65% 4.66% 8.58%
EBITDA Growth
0.00% 0.00% 0.00% -11.14% -4.90% -20.69% 9.50%
EBIT Growth
0.00% 0.00% 0.00% -11.14% -6.60% -400.00% 7.90%
NOPAT Growth
0.00% 0.00% 0.00% -9.16% -7.49% -375.00% 7.11%
Net Income Growth
0.00% 0.00% 0.00% -9.51% -1.63% -35.63% 14.42%
EPS Growth
0.00% 0.00% 0.00% -9.30% -2.00% -31.25% 14.67%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% 37.08% -4.67% 1.45%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 102.52%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.57%
Revenue Q/Q Growth
0.00% 6.26% 0.00% 0.00% 14.13% 0.00% 60.42%
EBITDA Q/Q Growth
0.00% 40.72% 0.00% 0.00% 50.60% 0.00% 501.24%
EBIT Q/Q Growth
0.00% 10.48% 0.00% 0.00% 16.12% 0.00% 1,046.67%
NOPAT Q/Q Growth
0.00% 14.86% 0.00% 0.00% 16.97% 0.00% 1,122.26%
Net Income Q/Q Growth
0.00% 16.70% 0.00% 0.00% 26.87% 0.00% 503.39%
EPS Q/Q Growth
0.00% 16.28% 0.00% 0.00% 25.64% 0.00% 509.52%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -149.57% 0.00% 0.00% -149.67% 146.99%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 1.34% 0.00% 102.44%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -0.82% 0.00% 0.54%
Profitability Metrics
- - - - - - -
Gross Margin
30.19% 30.24% 10.67% 30.00% 29.55% 9.69% 28.42%
EBITDA Margin
23.25% 30.79% 9.75% 20.81% 27.46% 7.39% 27.70%
Operating Margin
23.25% 24.49% -0.77% 20.78% 21.17% -3.49% 20.35%
EBIT Margin
23.25% 24.17% -0.72% 20.81% 21.17% -3.44% 20.32%
Profit (Net Income) Margin
14.59% 16.02% -4.18% 13.29% 14.78% -5.42% 13.62%
Tax Burden Percent
76.29% 78.52% 65.41% 77.96% 78.81% 81.38% 76.65%
Interest Burden Percent
82.23% 84.39% 886.67% 81.94% 88.56% 193.33% 87.46%
Effective Tax Rate
24.03% 22.05% 0.00% 22.22% 21.77% 0.00% 23.51%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -3.23% 10.49%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% -5.85% 9.24%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% -2.21% 3.97%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% -5.44% 14.47%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% -1.69% 10.24%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -2.66% 6.86%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% -5.44% 14.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
573 658 -11 520 609 -53 544
NOPAT Margin
17.66% 19.09% -0.54% 16.16% 16.56% -2.44% 15.57%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 3.30% 2.63% 2.62% 1.25%
Return On Investment Capital (ROIC_SIMPLE)
- - - 2.79% 3.25% -0.28% 2.88%
Cost of Revenue to Revenue
69.81% 69.76% 89.33% 70.00% 70.45% 90.31% 71.58%
SG&A Expenses to Revenue
7.03% 6.99% 11.48% 9.29% 8.49% 13.41% 8.10%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.94% 5.75% 11.44% 9.22% 8.38% 13.18% 8.07%
Earnings before Interest and Taxes (EBIT)
754 833 -15 670 778 -75 710
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
754 1,061 203 670 1,009 161 968
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 2.20 2.08 2.35 2.29
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 17.04 12.53 13.25 13.79
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 2.58 2.42
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 26.60 24.25
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.03%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 3.76% 4.12%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.83 1.78 1.98 1.92
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 3.00 2.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 12.83 12.13
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 19.29 18.28
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 25.19 23.93
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 16.46 16.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.50 0.45 0.46 0.47
Long-Term Debt to Equity
0.00 0.00 0.00 0.42 0.38 0.38 0.33
Financial Leverage
0.00 0.00 0.00 0.45 0.39 0.38 0.43
Leverage Ratio
0.00 0.00 0.00 1.91 1.86 1.85 1.91
Compound Leverage Factor
0.00 0.00 0.00 1.57 1.65 3.59 1.67
Debt to Total Capital
0.00% 0.00% 0.00% 33.27% 31.06% 31.60% 31.83%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 5.03% 4.70% 5.80% 9.38%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 28.24% 26.36% 25.80% 22.45%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% -0.01% -0.02% -0.03% -0.04%
Common Equity to Total Capital
0.00% 0.00% 0.00% 66.74% 68.96% 68.43% 68.21%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 2.17 2.09
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 1.78 1.84
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 1.77 1.48
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 4.27 4.13
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 3.49 3.63
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 3.48 2.91
Altman Z-Score
0.00 0.00 0.00 0.00 0.00 2.24 2.18
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% -0.05% -0.04%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 0.00 0.00 1.38 1.45 1.40 1.10
Quick Ratio
0.00 0.00 0.00 0.79 0.91 0.80 0.67
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -17,510 -17,274 -18,088 441
Operating Cash Flow to CapEx
0.00% 308.42% -409.57% 0.00% 474.44% -335.58% 169.76%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.49 0.50
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 8.77 6.17
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 5.67 5.71
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 1.42 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 8.71 6.75
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 41.61 59.13
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 64.34 63.96
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 41.92 54.11
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 64.03 68.98
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 0.00 0.00 18,030 17,883 18,035 18,133
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 1.32 0.67
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 18,030 17,883 18,035 103
Enterprise Value (EV)
0.00 0.00 0.00 33,002 31,863 35,692 34,774
Market Capitalization
0.00 0.00 0.00 27,406 26,881 30,751 29,507
Book Value per Share
$0.00 $0.00 $0.00 $22.48 $23.33 $23.67 $23.24
Tangible Book Value per Share
$0.00 $0.00 $0.00 $2.91 $3.88 $4.20 $3.87
Total Capital
0.00 0.00 0.00 18,631 18,709 19,134 18,862
Total Debt
0.00 0.00 0.00 6,198 5,811 6,046 6,004
Total Long-Term Debt
0.00 0.00 0.00 5,261 4,932 4,936 4,235
Net Debt
0.00 0.00 0.00 5,597 4,985 4,947 5,275
Capital Expenditures (CapEx)
0.00 202 209 0.00 180 267 248
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 1,519 1,470 1,241 1,470
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 2,120 2,296 2,340 2,199
Net Working Capital (NWC)
0.00 0.00 0.00 1,183 1,417 1,230 430
Net Nonoperating Expense (NNE)
100 106 76 92 66 65 68
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 5,597 4,985 4,947 5,275
Total Depreciation and Amortization (D&A)
0.00 228 218 0.00 231 236 258
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 10.42% 12.06%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 19.64% 18.04%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 10.33% 3.53%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.78 $0.99 ($0.21) $0.87
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 553.10M 553.10M 553.20M 552.50M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.78 $0.98 ($0.21) $0.86
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 553.10M 553.90M 553.20M 553.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 553.08M 553.08M 553.54M 546.93M
Normalized Net Operating Profit after Tax (NOPAT)
571 624 -12 519 605 -57 543
Normalized NOPAT Margin
17.59% 18.12% -0.57% 16.11% 16.48% -2.60% 15.54%
Pre Tax Income Margin
19.12% 20.40% -6.39% 17.05% 18.75% -6.66% 17.77%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Amrize’s first quarter of 2026 shows a sharp deterioration in profitability and cash generation compared with the stronger quarters in 2025 and 2024. Revenue held up reasonably well at $2.18 billion, but the company posted a net loss, burned cash from operations, and ended the quarter with a much weaker liquidity profile than it had at the end of 2025.

  • Revenue was $2.18 billion in Q1 2026, which indicates the business is still generating a large top line despite the downturn in earnings.
  • Gross profit was positive at $211 million, showing the company is still clearing raw product and production costs before overhead.
  • Cash and equivalents were $1.099 billion at quarter-end, up from $826 million in Q3 2025 and $601 million in Q2 2025.
  • Amrize produced a net cash inflow from financing activities of $743 million, supported by $777 million of debt issuance.
  • Depreciation remained sizable at $236 million, which continues to support operating cash flow quality over time.
  • Accounts receivable, inventories, and goodwill remain large balance-sheet items, reflecting a capital-intensive operating model and prior acquisitions.
  • Long-term debt was $4.94 billion, only slightly below the $4.93 billion level in Q3 2025, so leverage remains elevated but stable quarter to quarter.
  • The company recorded a large goodwill balance of $9.07 billion, which is something investors should watch for impairment risk if operating results stay weak.
  • Q1 2026 net income was a loss of $118 million, a steep reversal from the $543 million profit in Q3 2025 and $298 million in Q4 2025.
  • Operating income swung to a loss of $76 million, versus a profit of $778 million in Q3 2025, showing a major margin compression.
  • Operating cash flow was negative $896 million, driven by a massive $1.047 billion use of working capital.
  • Free cash flow was also under pressure, with $272 million of capital spending and $425 million of acquisitions adding to cash outflows.
  • Net change in cash and equivalents was negative $823 million in Q1 2026, compared with positive cash generation in the prior year period and a much stronger Q4 2025.
  • Interest and investment income was reported as a negative $70 million in Q1 2026, and total other expense was a $69 million drag on pre-tax results.
  • Short-term debt increased to $1.11 billion from $879 million in Q3 2025, while total current liabilities remained high at $3.054 billion.

Bottom line: Amrize entered 2026 with a solid revenue base and decent cash on hand, but the first quarter showed weak profitability, heavy working-capital pressure, and negative operating cash flow. The sharp drop from the stronger 2025 quarters suggests investors should watch whether this was a temporary reset or the start of a more durable earnings slowdown.

08/30/26 11:18 AM ETAI Generated. May Contain Errors.

Amrize Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amrize's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Amrize's net income appears to be on an upward trend, with a most recent value of $1.18 billion in 2025, rising from $955 million in 2023. The previous period was $1.27 billion in 2024. Check out Amrize's forecast to explore projected trends and price targets.

Amrize's total operating income in 2025 was $1.91 billion, based on the following breakdown:
  • Total Gross Profit: $3.03 billion
  • Total Operating Expenses: $1.13 billion

Over the last 2 years, Amrize's total revenue changed from $11.68 billion in 2023 to $11.82 billion in 2025, a change of 1.2%.

Amrize's total liabilities were at $11.09 billion at the end of 2025, a 20.2% decrease from 2024, and a 20.2% decrease since 2024.

In the past 1 years, Amrize's cash and equivalents has ranged from $1.59 billion in 2024 to $1.92 billion in 2025, and is currently $1.92 billion as of their latest financial filing in 2025.

Over the last 2 years, Amrize's book value per share changed from 0.00 in 2023 to 23.97 in 2025, a change of 2,397.1%.



Financial statements for NYSE:AMRZ last updated on 8/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners